İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Akademisyen

KADRİYE AĞAN YILDIRIM

PROFESÖR

MARMARA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Araştırma konuları OpenAlex
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 73
YÖKSİS73 OpenAlex0
Proje 12
Kitap 9
Bildiri 37

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 48
h-indeks 12 Türkiye yüzdelik dilimi: 90 Üniversitesinde h-indekse göre 195. / 2.128
i10-indeks
16
Toplam atıf
2.153
Türkiye’de üst %1,4
Makale başına
44,9
FWCI
3,10
1,00 = dünya ortalaması
Dünyada üst %1
2
Dünyada üst %10
4

En çok atıf alan makaleleri

  1. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study 2018 dünyada üst %1 947 atıf
  2. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial 2019 dünyada üst %1 742 atıf
  3. Morning headache in sleep apnoea clinical and polysomnographic evaluation and response to nasal continuous positive airway pressure 2009 dünyada üst %10 93 atıf

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 54
  • Q1 17
  • Q2 16
  • Q3 13
  • Q4 8
WoS (JCR) 54
  • Q1 13
  • Q2 9
  • Q3 14
  • Q4 18
TR Index TR Index

15 makale

OpenAlex atıf yüzdelik
  • Üst %1 2
  • Üst %10 5
  • Ort. 60.3%
  • n 70
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 76

WoS (JCR)

  • YÖKSİS satırı 76

TR Index

  • YÖKSİS satırı 18 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

39 dergi
Scopus (SJR)
Q1 17 Q2 16 Q3 13 Q4 8
WoS (JCR)
Q1 13 Q2 9 Q3 14 Q4 18
TR Index
15 makale

Makale listesi

  1. 2026 Evaluation and comparison of mortality scores in status epilepticus patients. BMC Neurology DOI https://link.springer.com/article/10.1186/s12883-025-04565-y YÖKSİS SJR Q2 JCR Q3
  2. 2025 Innsbruck REM Sleep Behavior Disorder Inventory may distinguish abnormal nocturnal movements related to obstructive sleep apnea Arquivos de Neuro-Psiquiatria DOI 10.1055/s-0045-1809543 YÖKSİS SJR Q3 JCR Q3 OpenAlex 9.4%
  3. 2025 Translation and linguistic validation study of Munich Parasomnia Screening tool for Turkish Sleep Medicine DOI 10.1016/j.sleep.2025.106762 YÖKSİS SJR Q1 JCR Q1 OpenAlex 16.0%
  4. 2025 Sex differences in clinical and polysomnographic features of obstructive sleep apnea: The Turkish sleep apnea database (TURKAPNE) cohort Sleep Medicine DOI 10.1016/j.sleep.2024.12.018 2 YÖKSİS kaydı YÖKSİS SJR Q1 JCR Q1 OpenAlex 84.2%
  5. 2025 Validity and reliability of the Turkish version of the Innsbruck RBD-9 diagnostic inventory (IRBD-9-TR) Arquivos de Neuro-Psiquiatria DOI 10.1055/s-0044-1800816 YÖKSİS SJR Q3 JCR Q3 OpenAlex 62.0%
  6. 2025 Effect of Telerehabilitation Exercise Program on Sleep Quality and Fatigue in Individuals With Multiple Sclerosis Annals of Rehabilitation Medicine DOI 10.5535/arm.250010 YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.1%
  7. 2025 Qualitative Insights into the Diagnosis, Treatment, and Socioeconomic and Psychological Challenges of Patients with Multiple Sclerosis in a Turkish Public Hospital journal of multiple sclerosis research DOI 10.4274/jmsr.galenos.2025.2024-5-1 YÖKSİS OpenAlex 61.7%
  8. 2025 Assessment of PAP Device Usage and COVID-19 Related Anxiety in Patients with OSAS During COVID-19 Pandemics THORACIC RESEARCH AND PRACTICE DOI 10.4274/ThoracResPract.2025.24029. YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 1.6%
  9. 2024 Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials LANCET NEUROLOGY DOI 10.1016/ S1474-4422(24)00328-4 YÖKSİS SJR Q1 JCR Q1
  10. 2024 Exploring Shared Triggers and Potential Etiopathogenesis between Migraine and Idiopathic/Genetic Epilepsy: Insights from a Multicenter Tertiary-Based Study Clinical Neurology and Neurosurgery DOI 10.1016/j.clineuro.2024.108146 3 YÖKSİS kaydı YÖKSİS SJR Q2 JCR Q3 OpenAlex 70.0%
  11. 2024 Assessment of Impact of Dietary Patterns on Obstructive Sleep Apnea Patients Sleep Science DOI 10.1055/s-0043-1776745 2 YÖKSİS kaydı YÖKSİS SJR Q2 JCR Q3 OpenAlex 50.0%
  12. 2024 Status Epilepticus Type, Etiology, and Treatment: One-year Data Archives Of Epilepsy DOI 10.4274/ArchEpilepsy.2023.23041 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 3.9%
  13. 2024 Epilepsy and Quality of Life in the Shadow of Stigmatization Medical Bulletin of Haseki DOI 10.4274/haseki.galenos.2024.9713 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 65.2%
  14. 2023 Correction: Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment Archives of Neuropsychiatry DOI 10.29399/npa.28499 3 YÖKSİS kaydı YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 43.9%
  15. 2023 Clinical and Demographic Characteristics of 508 Multiple Sclerosis Patients Using Fingolimod (Vintor) Treatment (Two-Year Efficacy and Reliability Data) ARCHIVES OF NEUROPSYCHIATRY DOI 10.29399/npa.28081 2 YÖKSİS kaydı YÖKSİS TR Index SJR Q3 JCR Q4
  16. 2023 In Vivo Corneal Confocal Microscopy in Multiple Sclerosis: Can it Differentiate Disease Relapse in Multiple Sclerosis? Elsevier BV DOI 10.1016/j.ajo.2023.01.015 2 YÖKSİS kaydı YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.6%
  17. 2023 Diagnosis of comorbid migraine without aura in patients with idiopathic/genetic epilepsy based on the gray zone approach to the International Classification of Headache Disorders 3 criteria Frontiers in neurology YÖKSİS SJR Q2 JCR Q2
  18. 2023 Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment Turk Noropsikiyatri Dernegi DOI 10.29399/npa.28081 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 43.9%
  19. 2023 Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting Multiple Sclerosis and Related Disorders DOI 10.1016/j.msard.2023.104880 3 YÖKSİS kaydı YÖKSİS SJR Q1 JCR Q2 OpenAlex 48.5%
  20. 2023 Real-life outcomes for oral disease-modifying treatments of relapsing-remitting multiple sclerosis patients: Adherence and adverse event profiles from Marmara University The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS DOI 10.55730/1300-0144.5640 2 YÖKSİS kaydı YÖKSİS OpenAlex 47.2%

Akademisyenlere dön